MENU

Publications

Preclinical development of a bispecific antibody-trap selectively targeting CD47 and CD20 for the treatment of B cell lineage cancer. Tian et al, AACR, 2019.

Date:2020-07-08 Views:15

POSTER: Preclinical development of a bispecific antibody-trap selectively targeting CD47 and CD20 for the treatment of B cell lineage cancer. Tian et al, AACR, 2019.